Working… Menu
Trial record 22 of 2159 for:    doxorubicin

Micro Needle Array-Doxorubicin (MNA-D) in Patients With Cutaneous T-cell Lymphoma (CTCL) (MNA-D)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02192021
Recruitment Status : Recruiting
First Posted : July 16, 2014
Last Update Posted : November 28, 2018
Information provided by (Responsible Party):
Oleg E. Akilov, MD, PhD, University of Pittsburgh